Published in Vaccine Weekly, June 11th, 2003
According to organizers, the conferences will examine the development of risk management plans and processes that will improve adverse drug reaction reporting in the pharmaceutical, biotechnology, and health care industries.
According to Julia Danilchenko, director of conference programming, "Managing and monitoring post-approval drug safety is critical in ensuring the benefit, effectiveness and risk of medicinal products as they affect individual patients and public health....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.